Health Care & Life Sciences » Pharmaceuticals | Ocular Therapeutix Inc.

Ocular Therapeutix Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
17,505.00
74,888.00
105,064.00
68,145.00
41,538.00
54,062
Total Accounts Receivable
269.00
329.00
193.00
250.00
226.00
201
Inventories
-
133.00
134.00
113.00
122.00
217
Other Current Assets
240.00
833.00
1,592.00
1,390.00
1,345.00
1,713
Total Current Assets
18,014.00
76,183.00
106,983.00
69,898.00
43,231.00
56,193
Net Property, Plant & Equipment
904.00
1,782.00
3,095.00
3,313.00
10,478.00
10,236
Total Investments and Advances
228.00
228.00
228.00
1,728.00
1,614.00
6,614
Other Assets
-
-
-
-
108.00
-
Total Assets
19,146.00
78,193.00
110,306.00
74,939.00
55,431.00
73,043
ST Debt & Current Portion LT Debt
1,806.00
1,354.00
-
1,549.00
5,545.00
Accounts Payable
545.00
1,316.00
1,957.00
2,116.00
3,571.00
Other Current Liabilities
991.00
3,204.00
3,421.00
4,635.00
4,310.00
Total Current Liabilities
3,342.00
5,874.00
5,378.00
8,300.00
13,426.00
Long-Term Debt
651.00
13,511.00
15,272.00
14,094.00
12,471.00
Other Liabilities
281.00
112.00
68.00
537.00
3,387.00
Total Liabilities
4,274.00
19,497.00
20,718.00
22,931.00
29,284.00
Common Equity (Total)
59,472.00
58,696.00
89,588.00
52,008.00
26,147.00
Total Shareholders' Equity
14,872.00
58,696.00
89,588.00
52,008.00
26,147.00
Total Equity
14,872.00
58,696.00
89,588.00
52,008.00
26,147.00
Liabilities & Shareholders' Equity
19,146.00
78,193.00
110,306.00
74,939.00
55,431.00
Preferred Stock (Carrying Value)
74,344.00
-
-
-
-

About Ocular Therapeutix

View Profile
Address
15 Crosby Drive
Bedford Massachusetts 01730
United States
Employees -
Website http://www.ocutx.com
Updated 07/08/2019
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S.